myoventive
myoventive.com
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
venBio Partners
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
venBio Partners Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Developing next-generation cell therapies utilizing engineered biomaterial technologies.
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
Protein Splicing to Develop the Next Generation of Genetic Medicines.
Kalium Health | Precision testing to transform the management of chronic kidney disease and heart disease.
ARCUS Genome Editing. At Precision BioSciences, we are using our novel ARCUS genome-editing technology to develop a new class of medicines…
Future Mobile. Press Developers Privacy Policy.
Overview
Home Privacy Policy Contact About About Us Myoventive is a precision-cardiology therapeutics company developing next-generation RNA-based medicines to transform the treatment of genetic heart disease.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco
United States
HQ
myoventive
600 Gateway Bvld, Suite 202, South San Francisco, CA 94080